Online first
Letter to the Editor
Published online: 2024-11-06
Atrial fibrillation in elderly patients with severe aortic stenosis. Authors’ reply
Pubmed: 39535948
Abstract
Not available
References
- Olasińska-Wiśniewska A, Urbanowicz T, Kübler P, et al. Increased parathyroid hormone concentration as a biomarker of atrial fibrillation in severe aortic stenosis. Kardiol Pol. 2024 [Epub ahead of print]; 82(11).
- Trevisan C, Rossi A, Curreri C. Increased parathyroid hormone concentration as a biomarker of atrial fibrillation in severe aortic stenosis: Editorial comment. Pol Heart J. 2024; 82(11).
- Verdoia M, Gioscia R, Nardin M, et al. Low levels of vitamin D and coronary artery disease: Is it time for therapy? Kardiol Pol. 2022; 80(4): 409–416.
- Kim IlY, Ye BM, Kim MJ, et al. 1,25-dihydroxyvitamin D deficiency is independently associated with cardiac valve calcification in patients with chronic kidney disease. Sci Rep. 2022; 12(1): 915.
- Maciorowska M, Uziębło-Życzkowska B, Gorczyca-Głowacka I, et al. Oral anticoagulation therapy in atrial fibrillation patients at high risk of bleeding: Clinical characteristics and treatment strategies based on data from the Polish multicenter register of atrial fibrillation (POL-AF). Pol Heart J. 2024; 82(1): 37–45.
- Liu Y, Xie X, Bi S, et al. Risk of osteoporosis in patients treated with direct oral anticoagulants vs. warfarin: an analysis of observational studies. Front Endocrinol (Lausanne). 2023; 14: 1212570.
